Who
Jennifer McKie Adams
Director
Company insider
Files Form 4 as: Director, Eton Pharmaceuticals.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $3.2M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 3 May 2021
- Last trade
- 31 Jul 2026
- Last filed
- 4 Aug 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Jul 2026filed 4 Aug 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 31 Jul 2026filed 4 Aug 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 17 Jun 2026filed 17 Jun 2026 | ETON Eton PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $189K50,000 at $3.78 | filing |
| 17 Jun 2026filed 17 Jun 2026 | ETON Eton PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.6M50,000 at $32.48 | filing |
| 17 Jun 2026filed 17 Jun 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —50,000 at $0.00 | filing |
| 17 Jun 2026filed 17 Jun 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —50,000 at $0.00 | filing |
| 17 Jun 2026filed 17 Jun 2026 | ETON Eton PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $189K50,000 at $3.78 | filing |
| 17 Jun 2026filed 17 Jun 2026 | ETON Eton PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.6M50,000 at $32.48 | filing |
| 12 Jan 2026filed 14 Jan 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —12,196 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —7,757 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —12,196 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —7,757 at $0.00 | filing |
| 3 Jan 2025filed 6 Jan 2025 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 13 Feb 2024filed 15 Feb 2024 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 3 Mar 2023filed 3 Mar 2023 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 7 Feb 2022filed 28 Feb 2022 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 3 May 2021filed 5 May 2021 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —28,133 at $0.00 | filing |
News
Eton (NASDAQ: ETON) secures LIBERVANT license with milestones up to $47.5 millionETON · themarketsdaily.com · 14 Oct 2026Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal FilmETON · manilatimes.net · 14 Oct 2026Comparing Cronos Group (NASDAQ:CRON) and Eton Pharmaceuticals (NASDAQ:ETON)ETON · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Jennifer McKie Adams; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.